Global Embolization Particle Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Embolization Particle market size will reach 3,316 Million USD in 2025 and is projected to reach 8,896.07 Million USD by 2032, with a CAGR of 15.14% (2025-2032). Notably, the China Embolization Particle market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Embolization particles, also known as embolic agents, are tiny materials used in medical procedures to block or occlude blood vessels or arteries. They are typically administered to manage various medical conditions, such as controlling bleeding, treating vascular malformations, or blocking the blood supply to tumors. These particles can be made of different materials, such as gelatin foam, microspheres, or coils, and are chosen based on the specific medical purpose. When introduced into the targeted blood vessel, embolization particles create a blockage, restricting or completely cutting off blood flow. This technique is employed to treat various medical conditions, often minimizing the need for more invasive surgeries and reducing the risk of complications.
The major global manufacturers of Embolization Particle include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, INterface BIOmaterials B.V., HENGRUI Medical, Alicon, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Embolization Particle. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Embolization Particle market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Embolization Particle market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Embolization Particle industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Embolization Particle Include:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
INterface BIOmaterials B.V.
HENGRUI Medical
Alicon
Embolization Particle Product Segment Include:
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Embolization Particle Product Application Include:
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Embolization Particle Industry PESTEL Analysis
Chapter 3: Global Embolization Particle Industry Porter's Five Forces Analysis
Chapter 4: Global Embolization Particle Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Embolization Particle Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Embolization Particle Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Embolization Particle Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Embolization Particle market size will reach 3,316 Million USD in 2025 and is projected to reach 8,896.07 Million USD by 2032, with a CAGR of 15.14% (2025-2032). Notably, the China Embolization Particle market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Embolization particles, also known as embolic agents, are tiny materials used in medical procedures to block or occlude blood vessels or arteries. They are typically administered to manage various medical conditions, such as controlling bleeding, treating vascular malformations, or blocking the blood supply to tumors. These particles can be made of different materials, such as gelatin foam, microspheres, or coils, and are chosen based on the specific medical purpose. When introduced into the targeted blood vessel, embolization particles create a blockage, restricting or completely cutting off blood flow. This technique is employed to treat various medical conditions, often minimizing the need for more invasive surgeries and reducing the risk of complications.
The major global manufacturers of Embolization Particle include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, INterface BIOmaterials B.V., HENGRUI Medical, Alicon, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Embolization Particle. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Embolization Particle market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Embolization Particle market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Embolization Particle industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Embolization Particle Include:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
INterface BIOmaterials B.V.
HENGRUI Medical
Alicon
Embolization Particle Product Segment Include:
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Embolization Particle Product Application Include:
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Embolization Particle Industry PESTEL Analysis
Chapter 3: Global Embolization Particle Industry Porter's Five Forces Analysis
Chapter 4: Global Embolization Particle Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Embolization Particle Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Embolization Particle Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Embolization Particle Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Embolization Particle Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Embolization Particle Product by Type
- 1.2.1 Microspheres
- 1.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
- 1.2.3 Drug-eluting Beads (DEBs)
- 1.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- 1.3 Embolization Particle Product by Application
- 1.3.1 Uterine Fibroid Embolization
- 1.3.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- 1.3.3 Liver Tumor Embolization
- 1.3.4 Trauma Embolization
- 1.3.5 Others
- 1.4 Global Embolization Particle Market Revenue and Sales Analysis
- 1.4.1 Global Embolization Particle Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Embolization Particle Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Embolization Particle Market Sales Price Trend Analysis (2020-2032)
- 1.5 Embolization Particle Market Development Status and Trends
- 1.5.1 Embolization Particle Industry Development Status Analysis
- 1.5.2 Embolization Particle Industry Development Trends Analysis
- 2 Embolization Particle Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Embolization Particle Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Embolization Particle Market Analysis by Country
- 4.1 Global Embolization Particle Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Embolization Particle Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Embolization Particle Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Embolization Particle Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Embolization Particle Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Embolization Particle Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Embolization Particle Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Embolization Particle Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Embolization Particle Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Embolization Particle Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Embolization Particle Average Sales Price by Manufacturers (2021-2025)
- 5.2 Embolization Particle Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Embolization Particle Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Embolization Particle Market Analysis by Type
- 6.1 Global Embolization Particle Market Revenue Analysis by Type
- 6.1.1 Global Embolization Particle Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Embolization Particle Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Embolization Particle Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Embolization Particle Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sirtex Medical
- 7.1.1 Sirtex Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sirtex Medical Embolization Particle Product Portfolio
- 7.1.3 Sirtex Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Merit Medical
- 7.2.1 Merit Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Merit Medical Embolization Particle Product Portfolio
- 7.2.3 Merit Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Cook Medical
- 7.3.1 Cook Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Cook Medical Embolization Particle Product Portfolio
- 7.3.3 Cook Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 BTG Medical
- 7.4.1 BTG Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 BTG Medical Embolization Particle Product Portfolio
- 7.4.3 BTG Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Boston Scientific Corporation
- 7.5.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Boston Scientific Corporation Embolization Particle Product Portfolio
- 7.5.3 Boston Scientific Corporation Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Terumo Corporation
- 7.6.1 Terumo Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Terumo Corporation Embolization Particle Product Portfolio
- 7.6.3 Terumo Corporation Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 INterface BIOmaterials B.V.
- 7.7.1 INterface BIOmaterials B.V. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
- 7.7.3 INterface BIOmaterials B.V. Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 HENGRUI Medical
- 7.8.1 HENGRUI Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 HENGRUI Medical Embolization Particle Product Portfolio
- 7.8.3 HENGRUI Medical Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Alicon
- 7.9.1 Alicon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Alicon Embolization Particle Product Portfolio
- 7.9.3 Alicon Embolization Particle Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Embolization Particle Industry Chain Analysis
- 8.2 Embolization Particle Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Embolization Particle Product Downstream Application Analysis
- 8.3.1 Global Embolization Particle Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Embolization Particle Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Embolization Particle Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Embolization Particle Typical Downstream Customers
- 8.5 Embolization Particle Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
